This is a demo store. No orders will be fulfilled.
Healthcare
Healthcare, the world's largest industry, is transforming faster than ever. The focus on outcomes based medicine and optimal health management of populations will result in major seismic shifts. Modernization and reform measures are being employed globally by public and private sector organizations to meet the growing need for healthcare. New technologies are being created, offering enormous promise to improve care delivery.
Our Transformational Health practice serves all key industry stakeholders through partnership models that provide access to high-quality content and our global team of industry experts. The practice includes Visionary Health, Life Sciences, Advanced Medical Technologies and Connected Health, focusing on evolving healthcare technologies and covering the entire industry spectrum
-
11 Jul 2014  |  Global  |  Market Research
Will Virtual CROs and Integrated Business Models Rule the Road
Insights into the innovative steps taken by CROs and pharmaceutical companies in the race for excellence and low-cost trials
This issue of Vital Signs, released on July 11, 2014, discusses game changing strategies in clinical research, including virtual clinical research organization (CRO) and the integrated business model.
$450.00 -
10 Jul 2014  |  North America  |  Market Research
Analysis of the US Molecular Imaging Informatics Market
Growth Opportunities in Nuclear and PET Imaging Informatics Subsist Despite Downward Pressures on Equipment Markets
This study provides an analysis of the US market for molecular imaging informatics solutions including nuclear imaging informatics, PET imaging informatics, and multimodality image fusion and comparison. The study assesses the size of the market based on its historic growth between 2010 and 2013, and projects future growth based on the current driv...
$2,450.00 -
03 Jul 2014  |  Asia Pacific  |  Market Outlook
2014 Asia-Pacific Medical Devices Outlook
Changing Demographics and Landscape Set Stage for the Future
Medical devices plays a key role in a vibrant healthcare industry. An increasing aging population with increasing communicable and non-communicale diseases and most governments providing subisidized healthcare translate the need for cost-effective medical devices. Governments need to meet these expectations by policy librealization and revamping re...
$3,950.00 -
03 Jul 2014  |  Global  |  Market Research
A Global Product and Pipeline Analysis of Antiretroviral Drug Development for the Treatment of HIV/AIDS
Antiretroviral Combinations Continue to Transform the Treatment Landscape
This research service focuses on antiviral/antiretroviral therapeutics for the treatment of HIV/AIDS. A product and pipeline assessment is provided for marketed and investigational products and combination regimens for the treatment of HIV infection. Segmentation by drug class is provided along with additional supporting information such as clinica...
$3,950.00 -
01 Jul 2014  |  Global  |  Market Research
Vital Signs - Healthcare News - The Analysts Perspective - June 2014
This issue of Vital Signs, released on July 1, 2014, discusses the FDA approval of Biogens Eloctate, Qiagens acquisition of Primera Dx, Roches acquisition of Genia Technologies, Cues at-home connected lab test, and the Credihealth Teen Clinic.
$450.00 -
30 Jun 2014  |  North America  |  Market Research
Carlsbad California
The Ideal Life Sciences Hub
There are a number of factors that influence a life sciences companys decision in selecting the perfect location for its research and development (R&D), manufacturing operations, or headquarters. This Vital Signs article discusses those factors and discusses why Carlsbad, California, is one ideal Life Sciences hub location. Case studies include I...
$250.00 -
26 Jun 2014  |  North America  |  Market Research
Impact of US Healthcare Reform on the In Vitro Diagnostics Market
Patient Influx and Increased Testing Will Steer Clinical Labs toward ACO Models
This Market Insight highlights the effects of the US Patient Protection and Affordable Care Act on the in vitro diagnostics (IVD) market, diagnostic test service providers, and IVD manufacturers. The deliverable also focuses on global trends and the outlook for the IVD market. Estimates and trends for all IVD segmentsimmunochemistry, point-of-care...
$2,450.00 -
26 Jun 2014  |  North America  |  Market Research
US Hematology Diagnostics Market
Longer Product Cycles Stall Market Growth
This research service analyzes and provides forecasts of the US hematology diagnostics market from 2012 to 2017. The market is broadly classified into 2 major segments: analyzers and reagents. The US hematology market was sized using a bottom-up revenue model developed from the actual installed base of hematology analyzers in US laboratories, the d...
$4,950.00 -
24 Jun 2014  |  Europe  |  Market Research
Western Europe In Vitro Diagnostics (IVD) Market Data
Poor Reimbursement Rates Affect the Growth of Promising IVD Segments
This study provides data for the Western European in vitro diagnostics (IVD) market. Haematology, haemostasis, urinalysis, microbiology, clinical chemistry, point-of-care testing, molecular diagnostics, tissue diagnostics, self-monitoring blood glucose and immunochemistry are the segments within this market. Market revenues have been included in th...
$3,950.00 -
20 Jun 2014  |  Europe  |  Market Research
Western Europe Urinalysis Market Data
Increased Pricing Pressures Due to Consolidation of Large and Small Hospitals
This market insight provides market data for the urinalysis market in Western Europe. Market segments include instruments and reagents. Instruments included are sediment, automated dipstick, and integrated analysers. Market revenues for instruments and reagents have been discussed for all of Western Europe—the United Kingdom, France, Germany, It...
$3,950.00